1. Home
  2. KSCP vs XLO Comparison

KSCP vs XLO Comparison

Compare KSCP & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KSCP
  • XLO
  • Stock Information
  • Founded
  • KSCP 2013
  • XLO 2016
  • Country
  • KSCP United States
  • XLO United States
  • Employees
  • KSCP N/A
  • XLO N/A
  • Industry
  • KSCP Telecommunications Equipment
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • KSCP Telecommunications
  • XLO Health Care
  • Exchange
  • KSCP Nasdaq
  • XLO Nasdaq
  • Market Cap
  • KSCP 35.9M
  • XLO 35.7M
  • IPO Year
  • KSCP 2022
  • XLO 2021
  • Fundamental
  • Price
  • KSCP $5.87
  • XLO $0.69
  • Analyst Decision
  • KSCP Strong Buy
  • XLO Buy
  • Analyst Count
  • KSCP 3
  • XLO 1
  • Target Price
  • KSCP $15.67
  • XLO $4.00
  • AVG Volume (30 Days)
  • KSCP 997.2K
  • XLO 302.3K
  • Earning Date
  • KSCP 08-13-2025
  • XLO 08-07-2025
  • Dividend Yield
  • KSCP N/A
  • XLO N/A
  • EPS Growth
  • KSCP N/A
  • XLO N/A
  • EPS
  • KSCP N/A
  • XLO N/A
  • Revenue
  • KSCP $11,468,000.00
  • XLO $9,274,000.00
  • Revenue This Year
  • KSCP $16.17
  • XLO $300.08
  • Revenue Next Year
  • KSCP $39.02
  • XLO $1.87
  • P/E Ratio
  • KSCP N/A
  • XLO N/A
  • Revenue Growth
  • KSCP N/A
  • XLO N/A
  • 52 Week Low
  • KSCP $2.45
  • XLO $0.62
  • 52 Week High
  • KSCP $28.57
  • XLO $1.70
  • Technical
  • Relative Strength Index (RSI)
  • KSCP 42.92
  • XLO 47.58
  • Support Level
  • KSCP $7.30
  • XLO $0.67
  • Resistance Level
  • KSCP $10.14
  • XLO $0.72
  • Average True Range (ATR)
  • KSCP 0.99
  • XLO 0.03
  • MACD
  • KSCP -0.24
  • XLO -0.00
  • Stochastic Oscillator
  • KSCP 0.94
  • XLO 41.30

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: